<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03372616</url>
  </required_header>
  <id_info>
    <org_study_id>MATCHY2017YZ</org_study_id>
    <nct_id>NCT03372616</nct_id>
  </id_info>
  <brief_title>coMparison Between invAsive and Non-invasive assessmenT on Blood Pressure and Cardiac Function in HealthY Participants</brief_title>
  <acronym>MATCHY</acronym>
  <official_title>coMparison Between invAsive and Non-invasive assessmenT on Blood Pressure and Cardiac Function in HealthY Participants: the MATCHY Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai 10th People's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a cross-sectional cohort study which aims to compare the invasive and non-invasive
      assessments on aortic blood pressure and cardiac funtion in subjects without history of
      cardio-vascular disease. Left ventricular (LV) filling pressure, LV volume, and aortic blood
      pressure will be measured invasively. Non-invasive assessment includes
      echocardiography,aortic, and carotid blood pressure measurement.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2018</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular filling pressure assessment with left heart catheterization</measure>
    <time_frame>1 day</time_frame>
    <description>All participants will receive invasive left ventricular filling pressure assessment with left heart catheterization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Left ventricular diastolic function assessment with echocardiography using ASE recommendations</measure>
    <time_frame>1 day</time_frame>
    <description>All participants will receive non-invasive left ventricular diastolic function assessment with echocardiography. The ASE-recommended (American Society of Echocardiography) creteria would be used to define left ventricular diastolic dysfunction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Left ventricular diastolic function assessment with echocardiography using EACVI recommendations</measure>
    <time_frame>1 day</time_frame>
    <description>All participants will receive non-invasive left ventricular diastolic function assessment with echocardiography. The EACVI-recommended (European Association of Cardiovascular Imaging) creteria would be used to define left ventricular diastolic dysfunction.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aortic blood presure obtained with Sphygmocor device</measure>
    <time_frame>1 day</time_frame>
    <description>Sphygmocor device (AtCor Medical, Australia) will be used in non-invasive aortic blood presure measurement with standard protocols shown in its user manual.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic blood presure obtained with PulsePen device</measure>
    <time_frame>1 day</time_frame>
    <description>PulsePen device (DiaTecne SRL, Italy) will be used in non-invasive aortic blood presure measurement with standard protocols shown in its user manual.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic blood presure obtained with Mobil-O-Graph device</measure>
    <time_frame>1 day</time_frame>
    <description>Mobil-O-Graph (IEM, Germany) device will be used in non-invasive aortic blood presure measurement with standard protocols shown in its user manual.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic blood presure obtained with catheterization</measure>
    <time_frame>1 day</time_frame>
    <description>Catheterization will be used in invasive aortic blood presure measurement. The cather will be placed in the aortic root while measuring the blood pressure.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Healthy Volunteer</condition>
  <arm_group>
    <arm_group_label>All participants</arm_group_label>
    <description>Aortic blood pressure, LV filling pressrue, and LV volume will be measured in all participants. Meanwhile, echocardiography and non-invasive aortic blood presure measurement will be performed. Three devices will be used in non-invasive aortic blood presure measurement, including Sphygmocor (AtCor Medical, Australia), PulsePen (DiaTecne SRL, Italy), and Mobil-O-Graph (IEM, Germany). In conclusion, all participants will receive invasive and non-invasive left ventricular diastolic function assessment, together with invasive and non-invasive aortic blood pressure assessment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Invasive left ventricular diastolic function assessment</intervention_name>
    <description>Left ventricular (LV) polyethylene catheter was inserted into left ventricular to directly measure LV filling pressure.</description>
    <arm_group_label>All participants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Invasive aortic blood pressure measurement</intervention_name>
    <description>Aortic blood pressure will be measured with polyethylene catheter in aortic root.</description>
    <arm_group_label>All participants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Non-Invasive left ventricular diastolic function assessment</intervention_name>
    <description>Echocardiography will be performed in all participants to assess left ventricular diastolic function non-invasively.</description>
    <arm_group_label>All participants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Non-Invasive aortic blood pressure measurement</intervention_name>
    <description>Three devices (Sphygmocor [AtCor Medical, Australia], PulsePen [DiaTecne SRL, Italy], and Mobil-O-Graph [IEM, Germany] ) will be used to assess aortic blood pressure non-invasively when participants are undergoing invasive aortic blood pressure measurement.</description>
    <arm_group_label>All participants</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with proposed coronary angiography and left left ventriculography but without
        diagnosed cardiovascular disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over or equal to 18 years old;

          -  Agree to participate the study and sign informed written consent;

          -  Any change of drugs which effect the hemodynamics during 1 month prior to enrollment;

          -  Proposed to perform coronary angiography and left left ventriculography in hospital;

        Exclusion Criteria:

          -  Non-sinus rhythm or frequent extra systoles;

          -  Identified coronary artery disease via coronary angiography;

          -  Diagnosed pulmonary vascular or parenchymal disease;

          -  Hypertrophic cardiomyopathy, restrictive cardiomyopathy, or constrictive pericarditis;

          -  Stenosis or insufficiency of valves (moderate and above);

          -  Heart transplant;

          -  Congenital heart disease;

          -  Inadequate imaging or doppler parameter quality in echocardiography.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yawei Xu, M.D., Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Shanghai 10th People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chen Chi, M.D.</last_name>
    <phone>086-150-2178-7802</phone>
    <email>chichen.david@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yi Zhang, M.D., Ph.D.</last_name>
    <phone>086-189-1768-6332</phone>
    <email>yizshcn@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Popescu BA, Waggoner AD. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016 Apr;29(4):277-314. doi: 10.1016/j.echo.2016.01.011.</citation>
    <PMID>27037982</PMID>
  </reference>
  <reference>
    <citation>Handoko ML, Paulus WJ. Polishing the diastolic dysfunction measurement stick. Eur J Echocardiogr. 2008 Sep;9(5):575-7. doi: 10.1093/ejechocard/jen181. Epub 2008 Jun 11.</citation>
    <PMID>18579489</PMID>
  </reference>
  <reference>
    <citation>McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson IB. Central blood pressure: current evidence and clinical importance. Eur Heart J. 2014 Jul;35(26):1719-25. doi: 10.1093/eurheartj/eht565. Epub 2014 Jan 23. Review.</citation>
    <PMID>24459197</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2017</study_first_submitted>
  <study_first_submitted_qc>December 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2017</study_first_posted>
  <last_update_submitted>December 9, 2017</last_update_submitted>
  <last_update_submitted_qc>December 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai 10th People's Hospital</investigator_affiliation>
    <investigator_full_name>Ya-Wei Xu</investigator_full_name>
    <investigator_title>Chief director of department of cardiology</investigator_title>
  </responsible_party>
  <keyword>aortic blood pressure</keyword>
  <keyword>diastolic dysfuntion</keyword>
  <keyword>echocardiography</keyword>
  <keyword>left ventricular ejection fraction</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

